PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.\', \'Clinical Lead, Quinton and Harborne PCN, Ridgacre House Surgery, Quinton, United Kingdom.\', \'Vaccine Taskforce, Department for Business, Energy and Industrial Strategy, London, United Kingdom.\', \'National infection Service, Public Health England, London, United Kingdom.\', \'National infection Service, Public Health England, Porton Down, Salisbury, United Kingdom.\', \'Oxford Immunotec Ltd, Abingdon, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.7554/eLife.69375e69375
?:doi
?:hasPublicationType
?:journal
  • eLife
is ?:pmid of
?:pmid
?:pmid
  • 34586068
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.121
?:rankingScore_hIndex
  • 74
is ?:relation_isRelatedTo_publication of
?:title
  • mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralization of P.1 Brazilian variant.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34586068>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34586068>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all